Specialty:
Breast Cancer Biology
Location:
University of Colorado Denver, Anschutz Medical Campus
Contact: (303) 724-3749 bolin.liu@ucdenver.edu
Prerequisites:
1 Year of college
Number of Openings: 1-2
Objective:
With the focus on the unique biological features of ErbB3 receptor in ErbB2-mediated breast cancer formation and progression, we hope to identify novel therapeutic agents for breast cancer patients with ErbB2-overexpressing tumors.
Description:
The student will gain basic knowledge of ErbB receptor signaling transduction pathways, learn cell culture techniques, cell proliferation assays, western blot analysis of protein expression and activation, evaluate therapeutic agents-induced apoptosis with ELISA, and explore the synergistic inhibitory effects of drug combinations on breast cancer cells.